Healthcare provider profile · identity verified

Shane Michael Lagore, NP

Nurse Practitioner · ADRIAN, MI · NPI 1386600468

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	594	151
Amlodipine Besylate	Amlodipine Besylate	408	98
Lisinopril	Lisinopril	355	91
Losartan Potassium	Losartan Potassium	330	81
Escitalopram Oxalate	Escitalopram Oxalate	320	66
Levothyroxine Sodium	Levothyroxine Sodium	298	73
Metformin Hcl	Metformin Hcl	271	78
Simvastatin	Simvastatin	200	48
Omeprazole	Omeprazole	196	53
Pantoprazole Sodium	Pantoprazole Sodium	194	51
Metoprolol Succinate	Metoprolol Succinate	179	43
Pravastatin Sodium	Pravastatin Sodium	151	44
Potassium Chloride	Potassium Chloride	150	37
Bumetanide	Bumetanide	144	29
Prednisone	Prednisone	142	84
Hydrochlorothiazide	Hydrochlorothiazide	131	36
Tamsulosin Hcl	Tamsulosin Hcl	130	37
Gabapentin	Gabapentin	129	25
Trazodone Hcl	Trazodone Hcl	128	34
Glimepiride	Glimepiride	119	29
Eliquis	Apixaban	115	23
Metoprolol Tartrate	Metoprolol Tartrate	113	30
Carvedilol	Carvedilol	95	22
Warfarin Sodium	Warfarin Sodium	92	15
Rosuvastatin Calcium	Rosuvastatin Calcium	91	36
Famotidine	Famotidine	83	25
Trulicity	Dulaglutide	82	18
Buspirone Hcl	Buspirone Hcl	80	16
Furosemide	Furosemide	79	21
Allopurinol	Allopurinol	76	22
Mirtazapine	Mirtazapine	76	13
Albuterol Sulfate Hfa	Albuterol Sulfate	74	28
Metformin Hcl Er	Metformin Hcl	72	25
Spironolactone	Spironolactone	71	21
Januvia	Sitagliptin Phosphate	70	18
Sertraline Hcl	Sertraline Hcl	63	11
Pioglitazone Hcl	Pioglitazone Hcl	59	12
Ezetimibe	Ezetimibe	56	11
Finasteride	Finasteride	56	17
Valsartan	Valsartan	55	11
Azithromycin	Azithromycin	54	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	14
Olmesartan Medoxomil	Olmesartan Medoxomil	49	15
Jardiance	Empagliflozin	47	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	suppressed
Tramadol Hcl	Tramadol Hcl	43	suppressed
Cephalexin	Cephalexin	42	32
Fluticasone Propionate	Fluticasone Propionate	42	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Alendronate Sodium	Alendronate Sodium	33	13
Diclofenac Sodium	Diclofenac Sodium	33	11
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Atenolol	Atenolol	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Xarelto	Rivaroxaban	24	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Nystatin	Nystatin	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Memantine Hcl	Memantine Hcl	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Amoxicillin	Amoxicillin	19	11
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	18
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Digoxin	Digoxin	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	11
Glipizide Er	Glipizide	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nyamyc	Nystatin	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Glipizide	Glipizide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error